Difficult/therapy‐resistant asthma

The need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies... von Ers Task Force on Difficult/therapy‐Resistant Asthma

Volltext

Difficult/therapy‐resistant asthmaThe need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies von Ers Task Force on Difficult/therapy-Resistant Asthma, Members of the Task Force: K.F. Chung and P. Godard (co-chairmen), E. Adelroth, J. Ayres, N. Barnes, P. Barnes, E. Bel, P. Burney, P. Chanez, G. Connett, C. Corrigan, J. de Blic, L. Fabbri, S.T. Holgate, P. Ind, G. Joos, H. Kerstjens, P. Leuenberger, C‐G. Lofdahl, S. McKenzie, H. Magnussen, D. Postma, M. Saetta, S. Salmeron, M. Silverman and P. Sterk

Volltext